259 related articles for article (PubMed ID: 28562687)
1. The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.
Li J; Li Y; Liu H; Liu Y; Cui B
PLoS One; 2017; 12(5):e0178515. PubMed ID: 28562687
[TBL] [Abstract][Full Text] [Related]
2. MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.
Byrne JA; Maleki S; Hardy JR; Gloss BS; Murali R; Scurry JP; Fanayan S; Emmanuel C; Hacker NF; Sutherland RL; Defazio A; O'Brien PM
BMC Cancer; 2010 Sep; 10():497. PubMed ID: 20846453
[TBL] [Abstract][Full Text] [Related]
3. Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system.
Wilson SH; Bailey AM; Nourse CR; Mattei MG; Byrne JA
Genomics; 2001 Aug; 76(1-3):81-8. PubMed ID: 11549320
[TBL] [Abstract][Full Text] [Related]
4. Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.
Shehata M; Bièche I; Boutros R; Weidenhofer J; Fanayan S; Spalding L; Zeps N; Byth K; Bright RK; Lidereau R; Byrne JA
Clin Cancer Res; 2008 Aug; 14(16):5050-60. PubMed ID: 18698023
[TBL] [Abstract][Full Text] [Related]
5. MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines.
Bhandari A; Shen Y; Sindan N; Xia E; Gautam B; Lv S; Zhang X
Biochem Biophys Res Commun; 2018 Oct; 504(2):434-439. PubMed ID: 30195491
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of miR-551b predicts poor prognosis and promotes tumorigenesis by targeting PTP4A3 in human colorectal cancer.
Sun HY; Qu ZC; Liu DM; Zhang W; Liu G; Zhu L
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5741-5751. PubMed ID: 31298325
[TBL] [Abstract][Full Text] [Related]
8. Expression of MYSM1 is associated with tumor progression in colorectal cancer.
Li Y; Li J; Liu H; Liu Y; Cui B
PLoS One; 2017; 12(5):e0177235. PubMed ID: 28498834
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
10. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
[TBL] [Abstract][Full Text] [Related]
11. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
12. B Subunit of Human Chorionic Gonadotropin Promotes Tumor Invasion and Predicts Poor Prognosis of Early-Stage Colorectal Cancer.
Li J; Yin M; Song W; Cui F; Wang W; Wang S; Zhu H
Cell Physiol Biochem; 2018; 45(1):237-249. PubMed ID: 29357321
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
14. miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.
Zheng GX; Qu AL; Yang YM; Zhang X; Zhang SC; Wang CX
World J Gastroenterol; 2016 Jun; 22(24):5589-97. PubMed ID: 27350737
[TBL] [Abstract][Full Text] [Related]
15. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
16. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.
Shen F; Li J; Cai W; Zhu G; Gu W; Jia L; Xu B
Oncol Rep; 2013 Sep; 30(3):1355-61. PubMed ID: 23784465
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
18. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma.
Wang Y; Chen CL; Pan QZ; Wu YY; Zhao JJ; Jiang SS; Chao J; Zhang XF; Zhang HX; Zhou ZQ; Tang Y; Huang XQ; Zhang JH; Xia JC
Oncotarget; 2016 Feb; 7(5):6323-34. PubMed ID: 26575170
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
Lin MX; Wen ZF; Feng ZY; He D
Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
